A detailed history of Kades & Cheifetz LLC transactions in Medtronic PLC stock. As of the latest transaction made, Kades & Cheifetz LLC holds 9,416 shares of MDT stock, worth $762,978. This represents 0.49% of its overall portfolio holdings.

Number of Shares
9,416
Previous 9,515 1.04%
Holding current value
$762,978
Previous $749 Million 13.19%
% of portfolio
0.49%
Previous 0.47%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$76.84 - $91.03 $7,607 - $9,011
-99 Reduced 1.04%
9,416 $848 Million
Q2 2024

Aug 12, 2024

BUY
$78.71 - $87.02 $14,010 - $15,489
178 Added 1.91%
9,515 $749 Million
Q1 2024

May 06, 2024

BUY
$82.84 - $88.09 $81,183 - $86,328
980 Added 11.73%
9,337 $814 Million
Q4 2023

Jan 29, 2024

BUY
$69.43 - $83.43 $1,110 - $1,334
16 Added 0.19%
8,357 $688 Million
Q3 2023

Oct 30, 2023

BUY
$78.22 - $90.4 $652,433 - $754,026
8,341 New
8,341 $654 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Kades & Cheifetz LLC Portfolio

Follow Kades & Cheifetz LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kades & Cheifetz LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kades & Cheifetz LLC with notifications on news.